Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Patients drive past lower-cost MRI options even after price shopping

The average person passed up six places offering cheaper scans compared to where they ultimately received treatment, but experts say providers and insurers are partially to blame.

chest pain lung pulmonary embolism

New pulmonary embolism approach could substantially reduce imaging overuse

The pretest probability score produced false-negative rates below 1% and dropped imaging use by about 20%, according to a new JAMA Cardiology study. 

Thumbnail

MRI study underscores patients don’t shop around for lower prices

A new study has reaffirmed that consumers don’t really shop around to find lower healthcare prices.

Physician practices suffered at the start of the pandemic

Physician spending fell 57% below pre-pandemic levels in April 2020, according to a new report from the American Medical Association that reveals changes in the Medicare program during the first six months of 2020.

appointment agenda scheduling exam

Radiology department busts imaging backlog by letting patients schedule their own exams

UCSF patients have arranged almost 5,000 exams on their own across six imaging centers, saving more than 400 hours of scheduler time. 

money maze payment reimbursement

Check please! AI expansion in radiology hinges on healthcare’s value proposition

Just last year CMS began reimbursing providers for using two algorithms, but experts say the current payment pathways may not entice private groups to follow the government's lead.

Thumbnail

CMS finally relents after decade of not covering PET imaging for infection, inflammation

It was back in 2008 that the federal agency decided not to reimburse for this exam, citing scant evidence at the time. 

Nanox

Nanox in direct contact with FDA reviewers as startup negotiates approval of novel imaging system

The Israel-based firm has been working for months to gain clearance for technology it believes will disrupt radiology with a fresh take on legacy X-ray scans.